CN Stock MarketDetailed Quotes
300519 Zhejiang Xinguang Pharmaceutical
- 15.50
- +0.02+0.13%
Market Closed Dec 13 15:00 CST
2.48BMarket Cap57.20P/E (TTM)
15.71High15.18Low73.05KlotVolume15.34Open15.48Pre Close112.87MTurnover6.40%Turnover Ratio38.56P/E (Static)160.00MShares17.5052wk High3.03P/B1.77BFloat Cap8.0552wk Low18.58Limit Up114.10MShs Float63.15Historical High12.38Limit Down3.42%Amplitude4.32Historical Low0.40Dividend TTM15.45Avg Price36.50KlotAsk2.58%Div YieldTTM100Lot Size34.09KlotBid
Zhejiang Xinguang Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 0.05%216.21M | -1.90%146.21M | 8.94%100.55M | -23.07%270.4M | -17.66%216.11M | -12.57%149.04M | -9.42%92.3M | 9.54%351.49M | 6.57%262.45M | 6.87%170.46M |
| Operating revenue | 0.05%216.21M | -1.90%146.21M | 8.94%100.55M | -23.07%270.4M | -17.66%216.11M | -12.57%149.04M | -9.42%92.3M | 9.54%351.49M | 6.57%262.45M | 6.87%170.46M |
| Other operating revenue | ---- | 5.26%57.5K | ---- | -1.33%114.97K | ---- | -0.40%54.63K | ---- | 8.28%116.52K | ---- | 7.12%54.84K |
| Total operating cost | 17.69%177.85M | 13.42%121.64M | 31.49%76.15M | -11.51%203.77M | -5.74%151.12M | 4.64%107.24M | 9.46%57.91M | 18.03%230.27M | 10.66%160.33M | 8.10%102.49M |
| Operating cost | 18.34%140.36M | 21.98%96.5M | 39.32%62.81M | -6.17%158.8M | -1.20%118.61M | 1.99%79.11M | 3.32%45.09M | 19.07%169.23M | 15.58%120.04M | 16.18%77.57M |
| Operating tax surcharges | 48.38%3.51M | 38.40%2.33M | 45.75%1.65M | 2.40%4.36M | -23.28%2.37M | -13.20%1.68M | -5.35%1.13M | 0.85%4.26M | -1.98%3.08M | -3.77%1.94M |
| Operating expense | -7.71%16.94M | -10.27%11.47M | 9.47%5.96M | -21.59%26.45M | -13.35%18.36M | -12.31%12.78M | -18.27%5.45M | 5.23%33.74M | -1.22%21.18M | -2.14%14.57M |
| Administration expense | -10.42%11.72M | -5.37%8.24M | -7.16%3.68M | 3.84%17.92M | 2.13%13.09M | 0.74%8.71M | 2.38%3.96M | -12.63%17.26M | -3.56%12.82M | -1.27%8.65M |
| Financial expense | 66.99%-4.31M | -41.97%-3.86M | -46.56%-1.89M | -93.45%-18.89M | -54.12%-13.07M | 64.32%-2.72M | 79.92%-1.29M | 41.16%-9.77M | -34.18%-8.48M | -89.33%-7.61M |
| -Interest Income (Financial expense) | 66.94%-4.32M | -41.80%-3.86M | -46.48%-1.89M | ---- | -54.07%-13.08M | 64.24%-2.72M | 79.89%-1.29M | ---- | -34.11%-8.49M | -89.15%-7.62M |
| Research and development | -18.23%9.62M | -9.35%6.96M | 10.17%3.95M | -2.67%15.13M | 0.75%11.76M | 4.08%7.67M | -9.71%3.58M | 15.01%15.55M | 23.55%11.68M | 15.14%7.37M |
| Credit Impairment Loss | -206.35%-390.43K | -100.33%-1.98K | -84.93%121.76K | 263.74%708.14K | 262.69%367.11K | 522.28%604.9K | 150.00%808.08K | -366.27%-432.48K | -31.76%-225.65K | -39.99%97.21K |
| Asset Impairment Loss | 55.89%-213.49K | 67.37%-197.91K | -65.27%-377.44K | -153.43%-503.34K | -6.51%-483.94K | -160.57%-606.47K | -590.06%-228.37K | 68.20%-198.61K | -75.57%-454.36K | 27.54%-232.75K |
| Other net revenue | -2.18%4.97M | 7.64%3.81M | 10.20%1.62M | 39.40%7.51M | 33.85%5.08M | 1.77%3.54M | 9.91%1.47M | -20.77%5.38M | -34.83%3.8M | 49.86%3.48M |
| Invest income | 13.95%3.62M | 22.90%2.49M | 109.15%1.1M | -5.63%4.07M | 3.78%3.17M | -18.42%2.03M | -13.19%523.93K | -32.75%4.32M | -39.40%3.06M | 61.38%2.48M |
| Asset deal income | -621.97%-67.85K | -621.97%-67.85K | -621.97%-67.85K | ---290.57K | --13K | --13K | --13K | ---- | ---- | ---- |
| Other revenue | 0.72%2.02M | 5.71%1.59M | 141.02%844.2K | 106.96%3.52M | 41.86%2.01M | 32.89%1.5M | -20.57%350.26K | 9.42%1.7M | 17.42%1.42M | 20.10%1.13M |
| Operating profit | -38.16%43.33M | -37.39%28.38M | -27.45%26.01M | -41.45%74.13M | -33.84%70.08M | -36.55%45.33M | -28.76%35.85M | -4.51%126.6M | -1.21%105.92M | 6.63%71.45M |
| Add:Non operating Income | 3,662.18%300.97K | 3,662.18%300.97K | 2,255.93%188.47K | 123.09%31.24K | -42.88%8K | -42.88%8K | -42.88%8K | -60.34%14.01K | -60.34%14.01K | -60.34%14.01K |
| Less:Non operating expense | 0.67%1.01M | --6.7K | --6.7K | -1.06%1M | -1.47%1M | ---- | ---- | 53.46%1.01M | -73.55%1.01M | --14.94K |
| Total profit | -38.30%42.63M | -36.75%28.68M | -26.96%26.19M | -41.75%73.16M | -34.15%69.09M | -36.54%45.34M | -28.76%35.86M | -4.82%125.6M | 1.46%104.92M | 6.57%71.45M |
| Less:Income tax cost | -53.35%4.84M | -53.41%3.17M | -37.93%3.36M | -47.54%8.8M | -33.09%10.39M | -36.09%6.8M | -28.00%5.41M | -5.06%16.78M | 0.56%15.52M | 6.16%10.65M |
| Net profit | -35.63%37.78M | -33.81%25.51M | -25.01%22.83M | -40.86%64.36M | -34.34%58.7M | -36.62%38.54M | -28.90%30.45M | -4.78%108.82M | 1.61%89.4M | 6.65%60.8M |
| Net profit from continuing operation | -35.63%37.78M | -33.81%25.51M | -25.01%22.83M | -40.86%64.36M | -34.34%58.7M | -36.62%38.54M | -28.90%30.45M | -4.78%108.82M | 1.61%89.4M | 6.65%60.8M |
| Net profit of parent company owners | -35.63%37.78M | -33.81%25.51M | -25.01%22.83M | -40.86%64.36M | -34.34%58.7M | -36.62%38.54M | -28.90%30.45M | -4.78%108.82M | 1.61%89.4M | 6.65%60.8M |
| Earning per share | ||||||||||
| Basic earning per share | -35.14%0.24 | -33.33%0.16 | -26.32%0.14 | -41.18%0.4 | -33.93%0.37 | -36.84%0.24 | -29.63%0.19 | -4.23%0.68 | 1.82%0.56 | 5.56%0.38 |
| Diluted earning per share | -35.14%0.24 | -33.33%0.16 | -26.32%0.14 | -41.18%0.4 | -33.93%0.37 | -36.84%0.24 | -29.63%0.19 | -4.23%0.68 | 1.82%0.56 | 5.56%0.38 |
| Other composite income | -96.13%16.61K | -169.19%-231.39K | -404.10%-407.24K | 705.96%869.74K | 240.11%429.7K | 10,126.03%334.44K | -35.17%133.92K | -140.55%-143.53K | -562.59%-306.68K | -101.99%-3.34K |
| Other composite income of parent company owners | -96.13%16.61K | -169.19%-231.39K | -404.10%-407.24K | 705.96%869.74K | 240.11%429.7K | 10,126.03%334.44K | -35.17%133.92K | -140.55%-143.53K | -562.59%-306.68K | -101.99%-3.34K |
| Total composite income | -36.07%37.8M | -34.98%25.28M | -26.67%22.42M | -39.98%65.23M | -33.63%59.13M | -36.06%38.87M | -28.93%30.58M | -5.20%108.68M | 1.19%89.09M | 6.33%60.8M |
| Total composite income of parent company owners | -36.07%37.8M | -34.98%25.28M | -26.67%22.42M | -39.98%65.23M | -33.63%59.13M | -36.06%38.87M | -28.93%30.58M | -5.20%108.68M | 1.19%89.09M | 6.33%60.8M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data